Risk factors for drug-resistant tuberculosis in the cattle-corridor region of south-western Uganda: a case-control study

Tuberculosis is an ancient bacterial infection that primarily attacks the lungs, spreading through the air when an infected person coughs or speaks. For decades, doctors have treated it with a combination of antibiotics, a strategy that usually cures the disease. However, in some cases, the bacteria learn to survive these medicines, becoming "drug-resistant." This means the standard pills no longer work, leaving patients sick for much longer and requiring more complex, expensive, and difficult treatments. In many parts of the world, this resistance is growing, turning a curable illness into a deadly one. Understanding why this happens in specific communities is crucial for stopping the spread, especially in rural areas where people live close to livestock and face unique challenges in getting medical care.

In the Ankole region of southwestern Uganda, a landscape defined by its vast cattle corridors where herders graze their animals, researchers set out to understand why drug-resistant tuberculosis was appearing in some people but not others. This area is characterized by rural livelihoods, close interaction between humans and animals, and variable access to health services. While the region has long reported cases of drug-resistant tuberculosis, there was little specific evidence explaining what factors made an individual more likely to develop this difficult-to-treat form of the disease. Was it the cattle? Was it poverty? Or was it something about how people managed their health? To find the answers, a team of researchers from Busitema University and the National TB and Leprosy Programme conducted a detailed study comparing two groups of people: those who had the drug-resistant form of tuberculosis and those who had the standard, treatable form.

The researchers worked in public health facilities across several districts in the Ankole region between January 2023 and September 2024. They identified 34 adults who had been confirmed to have drug-resistant tuberculosis and matched each of them with up to three other adults who had the standard, drug-susceptible version of the disease. These pairs were carefully matched by their age, sex, and the specific health facility and local area where they lived, ensuring that the comparison was fair and focused on the differences between the individuals rather than their surroundings. The team then interviewed all 131 participants, asking detailed questions about their lives, their health history, their daily habits, and the challenges they faced in getting medical care. They looked for patterns that might explain why the drug-resistant group was different from the standard group.

The study revealed that drug-resistant tuberculosis was not random; it was strongly linked to specific life circumstances and health histories. The most significant factor was a history of previous tuberculosis treatment. People who had been treated for tuberculosis before were twice as likely to have the drug-resistant form compared to those being treated for the first time. This suggests that past exposure to treatment, perhaps where the medicine was not taken fully or the bacteria were not fully cleared, played a major role. The researchers also found that having other chronic medical conditions, such as diabetes or high blood pressure, made a person nearly twice as likely to have drug-resistant tuberculosis. These conditions can weaken the body's defenses and complicate the treatment process.

Daily alcohol consumption emerged as another powerful predictor. People who drank alcohol every day were more than twice as likely to have drug-resistant tuberculosis compared to those who did not drink daily. The study noted that while drinking alcohol in general did not show a strong link, the frequency mattered; daily use was the key risk factor, likely because it interfered with the ability to take medicine consistently or attend medical appointments. Furthermore, financial barriers played a critical role. People who said their low income made it difficult to access tuberculosis care were one and a half times more likely to have the drug-resistant form. This highlights that even when medicines are free, the cost of traveling to a clinic or losing a day's wages can prevent people from getting the care they need, allowing the bacteria to become resistant.

Interestingly, the study found that tobacco smoking was actually less common among the people with drug-resistant tuberculosis, a result that surprised the researchers. However, they cautioned that this was likely due to the small number of smokers in the study or people under-reporting their habits, rather than smoking offering any protection. The researchers also investigated the role of cattle, given that the region is a major cattle corridor. While owning or caring for cattle was more common among the drug-resistant group in the initial look at the data, this link disappeared when other factors like income and health history were taken into account. This suggests that cattle ownership itself was not the direct cause, but rather a marker of the rural lifestyle and economic conditions that carried other risks.

The findings paint a clear picture of who is most vulnerable in this region. Drug-resistant tuberculosis is not just a medical failure but a reflection of repeated exposure to treatment, the burden of other chronic illnesses, the struggle of daily alcohol use, and the weight of financial hardship. The study did not find evidence that the cattle themselves were transmitting the drug-resistant bacteria, nor did it find that the disease was spreading primarily through raw milk consumption. Instead, the risk was concentrated in people who had already fought the disease before, those managing other long-term health issues, those struggling with daily alcohol habits, and those who could not afford the indirect costs of seeking care.

These results offer a roadmap for how to protect communities in the Ankole region and similar rural settings. The researchers suggest that health programs should pay special attention to anyone who has been treated for tuberculosis before, ensuring they get tested early for drug resistance and receive closer support. Integrating care for tuberculosis with treatment for other chronic diseases could help patients manage their health without missing appointments. Addressing daily alcohol use through screening and support within tuberculosis clinics could also prevent treatment failures. Finally, providing practical help like transport assistance or nutritional support could remove the financial barriers that currently allow the disease to become resistant. By focusing on these specific, real-world factors, health workers can better prevent the spread of drug-resistant tuberculosis and ensure that the medicines available today remain effective for tomorrow.